GRAL
GRAIL, Inc.
Nasdaq Services-Medical Laboratories
Emerging growth company

Key Financials

Net Income
$-408351000
↑ 79.9%
Operating Income
$-562163000
↑ 74.3%
Revenue
$147.2M
↑ 17.2%
EPS (Diluted)
$-11.11
↑ 82.5%
Cash & Equivalents
$249.7M
↑ 16.6%
Total Assets
$2.9B
↓ 2.1%
Shareholders' Equity
$2.6B
↑ 3.0%
Total Liabilities
$344.2M
↓ 28.3%

Recent SEC Filings

Form Type Filed Date Link
4 6/5/2026 View on SEC
4 6/3/2026 View on SEC
144 6/3/2026 View on SEC
3 6/2/2026 View on SEC
8-K 6/1/2026 View on SEC
SCHEDULE 13G/A 5/15/2026 View on SEC
SCHEDULE 13G/A 5/11/2026 View on SEC
10-Q 5/7/2026 View on SEC
8-K 5/5/2026 View on SEC
DEFA14A 4/28/2026 View on SEC

Company Information

Field Value
Ticker GRAL
Company Name GRAIL, Inc.
CIK 1699031
Sector Services-Medical Laboratories
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 8071
SIC Description Services-Medical Laboratories
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (833) 694-2553